Related Experiment Videos
Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Receptor Binding Assays and Drug Discovery.
Advances in pharmacology (San Diego, Calif.)·2018
Guidelines for manuscript submission in the peer-reviewed pharmacological literature.
Biochemical pharmacology·2015
GABA pharmacology: the search for analgesics.
Neurochemical research·2014
Characterization of GABA receptors.
Current protocols in pharmacology·2014
Prospects for neurodegenerative and psychiatric disorder drug discovery.
Expert opinion on drug discovery·2012
A legacy of discovery: from monoamines to GABA.
Neuropharmacology·2010
CE9A215 (inotodiol) ameliorates oxazolone-induced atopic dermatitis by targeting mast cells and proinflammatory cytokines.
The Journal of pharmacology and experimental therapeutics·2026
Mitochondrial proteomic signatures of postcardiac arrest brain injury reveal potential therapeutic targets.
The Journal of pharmacology and experimental therapeutics·2026
BE2012 a novel, REV-ERB antagonist that promotes regenerative myogenesis in vivo with substantially improved pharmacokinetics relative to SR8278.
The Journal of pharmacology and experimental therapeutics·2026
Prior Toll-like receptor 3 stimulation abolishes the ability of a MAPK/ERK kinase inhibitor to increase lipopolysaccharide-induced nitric oxide production concomitant with tumor necrosis factor-α suppression.
The Journal of pharmacology and experimental therapeutics·2026
Modafinil ameliorates sleep deprivation-induced memory impairment under acute hypobaric hypoxia via biphasic Cyp3a11 regulation and altered pharmacokinetics.
The Journal of pharmacology and experimental therapeutics·2026
Impact of Δ9-tetrahydrocannabinol and oxycodone coadministration on measures of antinociception, dependence, circadian activity, and reward in mice.
The Journal of pharmacology and experimental therapeutics·2026